Authors:
Ang, KK
Trotti, A
Brown, BW
Garden, AS
Foote, RL
Morrison, WH
Geara, FB
Klotch, DW
Goepfert, H
Peters, LJ
Citation: Kk. Ang et al., Randomized trial addressing risk features and time factors of surgery plusradiotherapy in advanced head-and-neck cancer, INT J RAD O, 51(3), 2001, pp. 571-578
Authors:
Forastiere, AA
Pfister, DG
Ang, K
Brockstein, B
Colevas, AD
Ellenhorn, J
Goepfert, H
Hicks, WL
Hong, WK
Kies, MS
Lydiatt, W
McCaffrey, T
Mittal, BB
Ridge, JA
Schuller, DE
Shah, JP
Spencer, S
Trotti, A
Urba, S
Weymuller, EA
Wheeler, RH
Wolf, GT
Citation: Aa. Forastiere et al., NCCN Practice Guidelines for head and neck cancers, ONCOLOGY-NY, 14(11A), 2000, pp. 163-194
Authors:
Fu, KK
Pajak, TF
Trotti, A
Jones, CU
Spencer, SA
Phillips, TL
Garden, AS
Ridge, JA
Cooper, JS
Ang, KK
Citation: Kk. Fu et al., A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003, INT J RAD O, 48(1), 2000, pp. 7-16
Authors:
Trotti, A
Byhardt, R
Stetz, J
Gwede, C
Corn, B
Fu, K
Gunderson, L
McCormick, B
Morris, M
Rich, T
Shipley, W
Curran, W
Citation: A. Trotti et al., Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy, INT J RAD O, 47(1), 2000, pp. 13-47
Authors:
Herskovic, A
Scott, C
Demas, W
Gaspar, L
Trotti, A
Citation: A. Herskovic et al., Accelerated hyperfractionation for bronchogenic cancer - Radiation TherapyOncology Group 9205, AM J CL ONC, 23(2), 2000, pp. 207-212
Citation: Aa. Forastiere et A. Trotti, Radiotherapy and concurrent chemotherapy: a strategy that improves locoregional control and survival in oropharyngeal cancer, J NAT CANC, 91(24), 1999, pp. 2065-2066
Authors:
Flood, W
Lee, DJ
Trotti, A
Spencer, S
Murphy, B
Khuri, F
DeConti, R
Wheeler, R
Forastiere, AA
Citation: W. Flood et al., Multimodality therapy of patients with locally advanced squamous cell cancer of the head and neck: Preliminary results of two pilot trials using paclitaxel and cisplatin, SEM RAD ONC, 9(2), 1999, pp. 64-69
Citation: A. Trotti et al., Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI) (vol 42, pg 257, 1998), INT J RAD O, 42(5), 1998, pp. 1181-1182